Apatinib-based neoadjuvant regimens show promise in resectable gastric cancer meta-analysis
A pooled analysis of 19 studies finds that neoadjuvant apatinib-based regimens achieve a 21 percent pathologic complete response rate in ...
A pooled analysis of 19 studies finds that neoadjuvant apatinib-based regimens achieve a 21 percent pathologic complete response rate in ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine